Inventor · disambiguated record
Michael Anthony Cawthorne
Also filed as: CAWTHORNE MICHAEL · CAWTHORNE MICHAEL A · CAWTHORNE MICHAEL ANTHONY
10 granted patents·10 pending applications·228 citations·filing 1974–2014
88Inventor score
Files withSOD CONSEILS RECH APPLIC4GW PHARMA LTD3BIOMEASURE INC2SMITHKLINE BEECHAM PLC2BEECHAM GROUP LTD1
Top patents by PatentIndex Score
20 records- 0196US4055635AFibrinolytic compositionsBEECHAM GROUP LTD·Filed 1974·Granted Oct 25, 1977·189 cites·9 claims
- 0281US7662784B2Method for decreasing body weight using a somatostatin receptor agonistIPSEN PHARMA SAS·Filed 2005·Granted Feb 16, 2010·2 cites·10 claims
- 0379US7033616B2Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their usePHYTOPHARM PLC·Filed 2001·Granted Apr 25, 2006·9 cites·19 claims
- 0463US2008020974A1Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome xCAWTHORNE MICHAEL A·Filed 2007·Application pending·0 cites
- 0559US2011082195A1New use for cannabinoidsGW PHARMA LTD·Filed 2009·Application pending·0 cites
- 0658US7256174B2Somatostatin and somatostatin agonists for treating insulin insensitivity and Syndrome XSOD CONSEILS RECH APPLIC·Filed 2003·Granted Aug 14, 2007·0 cites·5 claims
- 0756US2004048773A1Use of leptin antagonists for the treatment of diabetesSMITHKLINE BEECHAM PLC·Filed 2002·Application pending·0 cites
- 0855US2002160935A1Use of leptin antagonists for the treatment of diabetesSMITHKLINE BEECHAM PLC·Filed 2002·Application pending·0 cites
- 0954US7416744B2Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their useCONOPCO INC·Filed 2005·Granted Aug 26, 2008·0 cites·1 claims
- 1053US2016243075A2Tetrahydrocannabivarin (thc) for use in the protection of pancreatic islet cellsGW PHARMA LTD·Filed 2014·Application pending·0 cites
- 1149US2013245110A1Use for cannabinoidsGW PHARMA LTD·Filed 2013·Application pending·0 cites
- 1246US6004928AMethod of treating hyperlipidemiaBIOMEASURE INC·Filed 1998·Granted Dec 21, 1999·10 cites·23 claims
- 1346US5763200AInhibition of amylin releaseBIOMEASURE INC·Filed 1995·Granted Jun 9, 1998·12 cites·5 claims
- 1446US2002002181A1Use of leptin antagonists for the treatment of diabetesFiled 2001·Application pending·0 cites
- 1544US2004146951A1Inhibition of amylin releaseFiled 2004·Application pending·0 cites
- 1639US6774109B2Inhibition of amylin releaseSOD CONSEILS RECH APPLIC·Filed 1997·Granted Aug 10, 2004·4 cites·3 claims
- 1738US2013165446A1Benzo-or pyrido-imidazole derivativeFUJITA TAKASHI·Filed 2011·Application pending·0 cites
- 1832US7026289B2Method and compositions for treating hyperlipidemia and other conditionsSOD CONSEILS RECH APPLIC·Filed 1998·Granted Apr 11, 2006·2 cites·12 claims
- 1929US7034003B1Somatostatin and somatostatin agonists for decreasing body weightSOD CONSEILS RECH APPLIC·Filed 1998·Granted Apr 25, 2006·0 cites·6 claims
- 2026US2002042374A1Method of treating insulin insensitivity and syndrome xFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Anthony Cawthorne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →